drugset / Trial / NCT06378060
Clinical Study on Modified Allogeneic Hematopoietic Stem Cell Transplantation Regimen for Severe Aplastic Anemia
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study was to evaluate the safety and efficacy of a modified allogeneic hematopoietic stem cell transplantation regimen for aplastic anemia.
Timeline
- Start
- 2024-03-01
- Primary completion
- 2026-04-01
- Completion
- 2027-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cyclophosphamide | Other / unclassified | 50 mg/kg | — |
| Background | Fludarabine | Small molecule | 30 mg/m2 | — |
| Background | MMF | Unknown | 15 mg/kg | — |
| Background | Melphalan | Small molecule | 100 mg/m2 | — |
| Background | Modified transplantation system | Unknown | — | — |
| Background | PTCY | Unknown | 25 mg/kg | — |
| Background | Ruxolitinib | Small molecule | 2.5 mg | — |